Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Imaging: Cocaine Effects & Medication Development
NCT00000270Phase 4Withdrawn
- Sponsor
- New York State Psychiatric Institute
- Start
- Dec 1995
- Primary completion
- Dec 1995
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4 trial of cocaine in cocaine use disorder (CUD), sponsored by New York State Psychiatric Institute. Primary endpoints: Absolute change in regional cerebral blood flow at 15 minutes, Relative change in regional cerebral blood flow at 33 minutes and 1 more. Planned start Dec 1995; status: withdrawn.
02
Drugs
cocaine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT00000270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000270.